MM+M has announced its 40 Under 40 Class of 2024. Since debuting in 2020, the 40 Under 40 program has turned the spotlight on the abundance of young creatives, strategists and media people set to lead the medical marketing business into the decades ahead.

This year’s honorees hail from a wide range of health and wellness organizations, including pharma and biotech firms, manufacturers of medical devices and diagnostics, medical marketing agencies and health media companies.

“The medical marketing industry’s not-so-secret sauce is its focus on nurturing young talent,” said MM+M editor-in-chief Larry Dobrow. “As witnessed by the abundance of under-40 individuals in leadership roles, the industry’s investments have paid off, and then some. It’s a great privilege to get to know this year’s honorees, who are primed to lead the medical marketing business into the future.”

The 2024 class of 40 Under 40 will be honored at an event scheduled for February 15 in New York City. This year’s honorees are:

Jessica Akopyan, executive director, head of global media relations, Amgen

Henry Amato, VP, oncology business development, Haymarket Media Group

Marlo Benevento, senior associate director, marketing — cardiovascular, Boehringer Ingelheim

Ryan Billings, executive director, head of commercial innovation, Organon

Laurie Brown, executive director, global commercial product strategy, Gilead Sciences

Katie Buckley, global communications leader, vision, Johnson & Johnson MedTech

Lalitha Priya Chandrashekhar, founder and CEO, PFG MedComm

JohnMark Conklin, senior manager, global PR and communications, Publicis Health

Jazmin Correa, CX director, Merck

Annie Demetrio, head, global CRC therapeutic area, Takeda Oncology

Ozgun Demir, head of digital marketing, Genentech

Natxo Diaz, global head of health craft, VMLY&R Health

Victoria Driscoll, SVP, group account director, Wunderman Thompson Health

Ariane Dumas, director, U.S. oncology brand marketing, EMD Serono

Dana Fallaize, head of commercialization and analytics, U.S. neuromuscular, UCB

Dr. Chase Feiger, cofounder and CEO, Ostro

George Fernandez, president and CEO, Color & Culture

Christopher Girardi, head of performance marketing , Verily

Dr. Adam Goodcoff, CEO, MedFluencers

Will Hargreaves, client partner and senior integration partner, Real Chemistry

Baron Harper, senior director, global client development, pharma and consumer health, The Trade Desk

Binish Khan, VP, digital experience technology, Avalere Health

Skipper Kozelsky, senior director, marketing, respiratory biologics, AstraZeneca

Anna Kuchinsky, director, business development, Evoke Mind+Matter

Lynn Leber, VP, head of U.S. sales and marketing — systemic franchise, Apellis Pharmaceuticals

Hannah Lucas, director, product development – advertising, PurpleLab

Andrew Lyle, senior marketing manager, digital and media strategy — EGFR lung cancer franchise, AstraZeneca

Joe Malunda, group SVP, U.S. team and operations lead, digital, GCI Health

Liz Mansell, group director, HCP media planning and strategy, Initiative

Sarah McKeown-Cannon, VP, growth, Langland

Khari Motayne, VP, media, CMI Media Group

Quentin O’Brien, senior scientific director, Health & Wellness Partners

Alay Patel, associate director, digital/social design, Bristol Myers Squibb

Aridia Polanco, HCP Media Center of Excellence, Eli Lilly

Glenniss Richards, senior director, digital media activation, Bayer

Grace Rodriguez, DTC portfolio marketing head, immunology, UCB

Kelsey Ruegger, associate director, filler and skin quality marketing, Allergan Aesthetics

Kelly Sanderson Schrems, head of marketing, franchise A, oncology, AbbVie

Sneha Vats, EVP, Healthcasts Media

Rui Yang, marketing strategy lead — breast cancer HCP professional promotion, Novartis